Using Residual DNA Quantification Data To De-Risk mAb Development

Residual host cell DNA quantitation sits at the intersection of analytics, process development, and regulatory readiness. Far from a single-point assay, it can generate a continuous data stream that informs decisions across downstream purification steps. When applied to protein-rich environments, including high IgG matrices, assay performance reveals how sensitivity, recovery, and reproducibility hold up under manufacturing-realistic conditions. Those insights make it possible to compare unit operations, detect early signs of clearance risk, and strengthen process design before validation. Just as important, understanding how sample composition and process parameters influence results ensures assays remain dependable as workflows evolve.

Explore how a broader view of residual DNA data can support more confident, scalable development strategies.